SCHEMBL915196

SCHEMBL915196

Cc1ccc(CSCc2ccc(C)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.54
RECQL P46063 1/20 0.52
ALDH1A1 P00352 4/20 0.48
GAA P10253 1/20 0.48
ACHE P22303 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2A6 P11509 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
RAB9A P51151 2/20 0.45
TP53 P04637 1/20 0.45
MAPT P10636 1/20 0.45
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL76073 0.88 ACHE (0.59) IDO1RECQLALDH1A1GAAACHE
SCHEMBL12337765 0.87 IDO1 (0.48) IDO1RECQLALDH1A1GAAACHE
SCHEMBL14732513 0.86 IDO1 (0.44) IDO1RECQLALDH1A1GAAACHE
SCHEMBL8336169 0.85 IDO1 (0.47) IDO1RECQLALDH1A1GAACYP1A2
SCHEMBL11239117 0.85 IDO1 (0.47) IDO1RECQLALDH1A1GAAACHE
SCHEMBL13870175 0.83 RECQL (0.53) IDO1RECQLALDH1A1GAAMAPT
SCHEMBL19818189 0.83 IDO1 (0.45) IDO1RECQLALDH1A1GAACYP1A2
SCHEMBL25464628 0.82 BCHE (0.61) IDO1RECQLALDH1A1GAAACHE
SCHEMBL2802287 0.82 IDO1 (0.54) IDO1RECQLALDH1A1GAAACHE
SCHEMBL9866115 0.81 CYP1A2 (0.52) IDO1RECQLALDH1A1GAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119371674-A Preparation method of donor-acceptor type metal organic framework photocatalyst and application of photocatalytic amine oxide/thioether 长沙理工大学 2025-01-28 CN claimed
CN-119371674-A Preparation method of donor-acceptor type metal organic framework photocatalyst and application of photocatalytic amine oxide/thioether 长沙理工大学 2025-01-28 CN disclosed
CN-119318976-A Doped metal halide perovskite photocatalyst and preparation method and application thereof 东华理工大学 2025-01-17 CN disclosed
EP-4139281-B1 SULFUR EXTRUSION FROM DISULFIDES BY CARBENES UNIV HEIDELBERG (DE) 2024-05-08 EP disclosed
CN-116981659-A Process for preparing enantiomerically enriched (2Z) -2- (phenylimino) -1, 3-thiazolidin-4-one sulfoxide derivatives 拜耳公司 2023-10-31 CN disclosed
WO-2023095615-A1 EPOXY RESIN COMPOSITION, CURED PRODUCT THEREOF, AND LAMINATE DIC株式会社 2023-06-01 WO disclosed
US-20230151054-A1 SULFUR EXTRUSION FROM DISULFIDES BY CARBENES Universität Heidelberg (DE) 2023-05-18 US disclosed
US-20230151054-A1 SULFUR EXTRUSION FROM DISULFIDES BY CARBENES Universität Heidelberg (DE) 2023-05-18 US disclosed
US-20230151054-A1 SULFUR EXTRUSION FROM DISULFIDES BY CARBENES Universität Heidelberg (DE) 2023-05-18 US disclosed
CN-112608257-B Synthesis method of sulfoxide compound 新疆大学 2023-04-07 CN disclosed
EP-0309953-A1 5-Substituted-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methyl-isoxazolidines FISONS CORPORATION (US) 1989-04-05 EP disclosed
US-4505860-A Cyclic keto-butyraldehydes a process for their preparation, and their use in the preparation of cyclic diisocyanates BAYER AKTIENGESELLSCHAFT (DE) 1985-03-19 US disclosed
EP-0100479-B1 3-(AMINOMETHYL)-1-(3-AMINOPROPYL-1-METHYL)-4-METHYL CYCLOHEXANE, PROCESS FOR ITS PREPARATION AND ITS USE BAYER AG (DE) 1985-03-13 EP disclosed
US-4487966-A 3-Aminomethyl-1-(3-aminopropyl-1-methyl)-4-methylcyclohexane, a process for its preparation and its use BAYER AKTIENGESELLSCHAFT (DE) 1984-12-11 US disclosed
EP-0074561-B1 CYCLIC CETO-BUTYRALDEHYDES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE PREPARATION OF CYCLIC DIISOCYANATES BAYER AG (DE) 1984-11-21 EP disclosed
EP-0100479-A1 3-(Aminomethyl)-1-(3-aminopropyl-1-methyl)-4-methyl cyclohexane, process for its preparation and its use BAYER AG (DE) 1984-02-15 EP disclosed
EP-0008763-B1 AMINOMETHYL-CYCLODODECANES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTICORROSIVES BAYER AG (DE) 1981-04-01 EP disclosed
US-4251462-A REACTING 1,5,9-CYCLODODECATRIENE WITH CARBON MONOXIDE AND HYDROGEN, REMOVING CATALYST, REACTING WITH HYDROGEN AND AMMONIA BAYER AKTIENGESELLSCHAFT (DE) 1981-02-17 US disclosed
EP-0008763-A1 Aminomethyl-cyclododecanes, a process for their preparation and their use as anticorrosives BAYER AG (DE) 1980-03-19 EP disclosed
US-4120866-A REACTING AN AROMATIC COMPOUND WITH A SULFOXIDE BAYER AKTIENGESELLSCHAFT (DE) 1978-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151054-A1 SULFUR EXTRUSION FROM DISULFIDES BY CARBENES TST, CBS, CTH IDO1 1812/4885RECQL 3473/4885ALDH1A1 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.